DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Sertraline
First Posted Date
2010-12-28
Last Posted Date
2012-01-11
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
32
Registration Number
NCT01267383
Locations
🇮🇳

Veeda Clinical Research (P) Ltd, Ambawadi, Ahmedabad, India

Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Finasteride
First Posted Date
2010-12-21
Last Posted Date
2010-12-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01264289
Locations
🇺🇸

Novum Pharmaceutical Research Services, Las Vegas,, Nevada, United States

Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Finasteride
First Posted Date
2010-12-21
Last Posted Date
2010-12-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01264302
Locations
🇺🇸

Novum Pharmaceutical Research Services, Las Vegas,, Nevada, United States

Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Device: Prilosec® 40 mg
Drug: Omeprazole
First Posted Date
2010-07-27
Last Posted Date
2010-07-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01170182

Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Omeprazole
Drug: Prilosec
First Posted Date
2010-07-27
Last Posted Date
2010-07-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
44
Registration Number
NCT01170169

Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Simvastatin
First Posted Date
2010-07-22
Last Posted Date
2010-08-09
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
44
Registration Number
NCT01167933

Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Simvastatin
First Posted Date
2010-07-22
Last Posted Date
2010-07-22
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
72
Registration Number
NCT01167894

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Fluoxetine Hydrochloride
First Posted Date
2010-07-20
Last Posted Date
2010-07-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01166100
Locations
🇮🇳

Lotus Labs Private Limited, Mylapore, Chennai, India

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Fluoxetine Hydrochloride
First Posted Date
2010-07-20
Last Posted Date
2010-07-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01166087
Locations
🇮🇳

Lotus Labs Private Limited, Mylapore, Chennai, India

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Altace
Drug: Ramipril
First Posted Date
2010-07-19
Last Posted Date
2010-07-19
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01164774
Locations
🇮🇳

Lambda Therapeutic Research Limited, Ahmedabad, Gujrat, India

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy